{"nct_id":"NCT02675426","title":"A Study Comparing Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis on a Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response to csDMARDs Alone","status":"COMPLETED","status_verified_date":"2023-03","start_date":"2015-12-17","start_date_type":"ACTUAL","primary_completion_date":"2017-04-21","primary_completion_date_type":"ACTUAL","completion_date":"2022-03-10","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["ABBV"]}